EntryPoint Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,281
| Closed | -$210K | – | 837 |
|
|
2024
Q4 | $210K | Buy |
54,281
+36,045
| +198% | +$139K | 0.09% | 576 |
|
|
2024
Q3 | $119K | Buy |
+18,236
| New | +$119K | 0.07% | 544 |
|
|
2024
Q2 | – | Sell |
-13,927
| Closed | -$106K | – | 1306 |
|
|
2024
Q1 | $106K | Buy |
+13,927
| New | +$106K | 0.09% | 392 |
|